EF
TEVA icon

Empowered Funds’s Teva Pharmaceuticals TEVA Stock Holding History

Empowered Funds’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
92,925
+55,495
+148% +$1.85M 0.02% 940
2026
Q1 		$1.13M Buy
+37,430
New +$1.2M 0.01% 1369

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Empowered Funds's TEVA Position: Q2 2026 in Review

Empowered Funds increased its Teva Pharmaceuticals (TEVA) stake by 148% in Q2 2026, buying an estimated $1.85M and bringing the position to 92,925 shares worth $3.15M. The position accounts for 0.02% of the portfolio, ranked #940.

Empowered Funds first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Empowered Funds held 92,925 shares of Teva Pharmaceuticals worth $3.15M as of Q2 2026.
  • Empowered Funds bought 55,495 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.85M.
  • Teva Pharmaceuticals made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #940 holding.
  • Empowered Funds first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.